Bliss GVS Pharma Limited (NSE:BLISSGVS)
436.55
+11.90 (2.80%)
Jun 11, 2026, 3:30 PM IST
Bliss GVS Pharma Market Cap
Bliss GVS Pharma has a market cap or net worth of 46.13 billion as of June 11, 2026. Its market cap has increased by 247.03% in one year.
Market Cap
46.13B
Enterprise Value
45.05B
Revenue
8.68B
Ranking
n/a
PE Ratio
42.28
Stock Price
436.55
Market Cap Chart
Since January 11, 2002, Bliss GVS Pharma's market cap has increased from 10.05M to 46.13B, an increase of 458,809.28%. That is a compound annual growth rate of 41.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 11, 2026 | 46.13B | 166.70% |
| Dec 31, 2025 | 17.30B | -0.33% |
| Dec 31, 2024 | 17.35B | 33.41% |
| Dec 29, 2023 | 13.01B | 72.15% |
| Dec 30, 2022 | 7.56B | -29.58% |
| Dec 31, 2021 | 10.73B | -48.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Strides Pharma Science | 93.74B |
| Akums Drugs and Pharmaceuticals | 83.94B |
| Sudeep Pharma | 82.44B |
| Sun Pharma Advanced Research Company | 67.89B |
| Aarti Pharmalabs | 54.97B |
| Innova Captab | 52.34B |
| Orchid Pharma | 43.61B |
| RPG Life Sciences | 34.55B |